Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Eptifibatide Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Eptifibatide Manufacturers in India Suppliers Eptifibatide Exporters Distributors Eptifibatide api active pharmaceuticals ingredients Eptifibatide manufacturers Side Effects bulk drugs raw material Eptifibatide companies Side Effects Importers Eptifibatide Eptifibatide Exporters Eptifibatide exporters FDA Eptifibatide DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Eptifibatide manufacturing pharmaceutical drugs pharmaceutical intermediates Eptifibatide pharmaceutical chemicals pharmaceutical raw materials Eptifibatide active pharmaceutical ingredients Eptifibatide committee active pharmaceutical ingredients manufacturer Eptifibatide Active Pharmaceutical Ingredients manufacturer Eptifibatide exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Eptifibatide, Eptifibatide manufacturer India, Eptifibatide product, Eptifibatide products, Api preparation, Certificate of Analysis API manufacturer product, Eptifibatide anti ulcer product, Certificate of Origin COA Eptifibatide COS Eptifibatide, pharmaceutical generic, pharmaceutical drug, medical, Eptifibatide pharma healthcare, pharma patents, contract MSDS manufacturing Trader Eptifibatide pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Eptifibatide expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Eptifibatide DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Eptifibatide ingredients, api, HIV Eptifibatide, tablets, capsules, syrup & protein Eptifibatide powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Eptifibatide gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Eptifibatide WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Eptifibatide Chemical-data





















 








 

 

HOME >> API >> API List1 >> Eptifibatide >> Precautions

CAS no.: 188627-80-7 Molecular Structure Eptifibatide

PRECAUTIONS
Eptifibatide CAS no.: 188627-80-7

Bleeding: The most common complication is bleeding, including retroperitoneal, pulmonary, and spontaneous GI and/or GU bleeding; watch closely for bleeding, especially the arterial access site for the cardiac catheterization. Use with extreme caution in patients with platelet counts <150,000/mm3, patients with hemorrhagic retinopathy, previous history of GI disease, recent thrombolytic therapy and in chronic dialysis patients. Use caution with administration of other drugs affecting hemostasis. Minimize other procedures including arterial and venous punctures, I.M. injections, nasogastric tubes, etc.

Before using Eptifibatide :

Some medical conditions may interact with Eptifibatide . Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

* if you are pregnant, planning to become pregnant, or are breast-feeding
* if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
* if you have allergies to medicines, foods, or other substances
* if you have kidney problems or high serum creatinine levels, high blood pressure, or low blood platelet levels (eg, thrombocytopenia)

Some MEDICINES MAY INTERACT with Eptifibatide . Tell your health care provider if you are taking any other medicines, especially any of the following:

* Anticoagulants (eg, warfarin, heparin), aspirin, dipyridamole, nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), or thrombolytics (eg, alteplase) because risk of bleeding may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Eptifibatide may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS >>
INTERACTION
PHARMALOGY
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Eptifibatide

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.